Gapping down
News:
- CAPR -12.9% (announces positive Type-B meeting with the FDA to discuss pathway to BLA for CAP-1002 in Duchenne muscular dystrophy)
- GCT -5.7% (responds to claims made in a report by Culper Research a short seller)
- EBIX -4.1% (to be removed from S&P Small Cap 600)
- HA -2.8% (to be removed from S&P Small Cap 600)
- OPRA -2.2% (prices secondary offering of 6876506 ADSs to be sold by a pre-IPO shareholder at $12.25 per ADS)
- ASTL -2% (provides SepQ operating guidance)
- AVD -1.9% (to be removed from S&P Small Cap 600)
- IBP -1.7% (COO to retire names new COO)
- EAF -1.1% (CEO to step down)